Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

HSTO holding history

Histogen Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HSTO overviewAll 13F holders of HSTOFull Q2 2026 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
5
Since Q1 2021
Holdings of HSTO by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−10,551−100.0%Sold outHolders
Q2 202210,551$24.0K<0.1%+10,551NewHolders
Q1 20220$00.0%−51,192−100.0%Sold outHolders
Q4 202151,192$17.0K<0.1%+16,752+48.6%AddedHolders
Q3 202134,440$26.0K<0.1%−60,510−63.7%ReducedHolders
Q2 202194,950$103.0K<0.1%+21,471+29.2%AddedHolders
Q1 202173,479$95.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.